BridgeMD
New treatment option for Hyperkypohsis and Impaired Lung Function
Official title Costovertebral Mobilization on Kyphotic Posture and Lung Function in Non-Smoker
ClinicalTrials.gov ID: NCT06530056
What this study is testing
- What it's testing
- Aim of this study is to find the effects of Costoverterbral Mobilization on Thoracic kyphosis and Lung function in non-smoker. A randomized control trial that will include total 44 participants.The first group will receive Costovertebral Mobilization along with conventional therapy and 2nd group will receive conventional therapy.Data collected will be analyzed through SPSS 25
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40
You may be able to join if
- Non smoker
- Age: 20-40 years
- Normal Body Mass Index 18.5 To 24.9
- Both female and male gender
- Decrease forced expiratory volume-one second/ forced vital capacity ratio greater than or equal to 70%
You likely can't join if
- Any respiratory disease of the upper or lower respiratory tracts e.g. asthma, chronic bronchitis, COPD, emphysema etc. which could altered the...
- Previous history of rib fractures, dislocations, sprains of costochondral, costosternal and interchondral joints.
- Smokers
- Scheuermann Disease
- Primary and Secondary neoplastic lesions of the spine and/or ribs
- Obvious advanced spinal deformity e.g. kyphoscoliosis
See the full eligibility criteria
- Non smoker
- Age: 20-40 years
- Normal Body Mass Index 18.5 To 24.9
- Both female and male gender
- Decrease forced expiratory volume-one second/ forced vital capacity ratio greater than or equal to 70%
- Increase Thoracic kyphotic posture greater than or equal to 40˚
- Any respiratory disease of the upper or lower respiratory tracts e.g. asthma, chronic bronchitis, COPD, emphysema etc. which could altered the optimal lung functioning.
- Previous history of rib fractures, dislocations, sprains of costochondral, costosternal and interchondral joints.
- Smokers
- Scheuermann Disease
- Primary and Secondary neoplastic lesions of the spine and/or ribs
- Obvious advanced spinal deformity e.g. kyphoscoliosis
- Infection e.g. tuberculosis
- Primary and secondary neoplastic lesions of the soft tissue structures of the chest
- Inflammation e.g. acute rheumatoid arthritis or ankylosing spondylitis
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.